Follow
Fernando Bartolome Robledo
Fernando Bartolome Robledo
12 de Octubre Research Institute
Verified email at h12o.es
Title
Cited by
Cited by
Year
Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction
KJ Kinghorn, JI Castillo-Quan, F Bartolome, PR Angelova, L Li, S Pope, ...
Brain 138 (7), 1801-1816, 2015
1922015
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels
F Bartolome, HC Wu, VS Burchell, E Preza, S Wray, CJ Mahoney, NC Fox, ...
Neuron 78 (1), 57-64, 2013
1802013
Measurement of mitochondrial NADH and FAD autofluorescence in live cells
F Bartolomé, AY Abramov
Mitochondrial Medicine: Volume I, Probing Mitochondrial Function, 263-270, 2015
1722015
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin
E Carro, F Bartolomé, F Bermejo-Pareja, A Villarejo-Galende, JA Molina, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 131-138, 2017
1672017
Mutations in HPCA cause autosomal-recessive primary isolated dystonia
G Charlesworth, PR Angelova, F Bartolomé-Robledo, M Ryten, ...
The American Journal of Human Genetics 96 (4), 657-665, 2015
982015
Decreased salivary lactoferrin levels are specific to Alzheimer's disease
M González-Sánchez, F Bartolome, D Antequera, V Puertas-Martín, ...
EBioMedicine 57, 2020
902020
Amyloid β-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition
F Bartolome, M de la Cueva, C Pascual, D Antequera, T Fernandez, C Gil, ...
Alzheimer's Research & Therapy 10, 1-15, 2018
812018
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
L Martínez-González, C Rodríguez-Cueto, D Cabezudo, F Bartolomé, ...
Scientific reports 10 (1), 4449, 2020
672020
Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates
F Bartolome, N Esteras, A Martin-Requero, C Boutoleau-Bretonniere, ...
Scientific reports 7 (1), 1666, 2017
672017
Enhanced proteasome-dependent degradation of the CDK inhibitor p27kip1 in immortalized lymphocytes from Alzheimer's dementia patients
U Munoz, F Bartolomé, F Bermejo, Á Martín-Requero
Neurobiology of aging 29 (10), 1474-1484, 2008
582008
Kynurenic acid levels are increased in the CSF of Alzheimer’s disease patients
M González-Sánchez, J Jiménez, A Narváez, D Antequera, ...
Biomolecules 10 (4), 571, 2020
542020
Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions
F Bermejo‐Pareja, T Del Ser, M Valentí, M de la Fuente, F Bartolome, ...
Alzheimer's & Dementia 16 (8), 1196-1204, 2020
532020
HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of …
SG Sala, U Munoz, F Bartolome, F Bermejo, Á Martín-Requero
Journal of Pharmacology and Experimental Therapeutics 324 (1), 352-359, 2008
512008
Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
M de la Cueva, D Antequera, L Ordoñez-Gutierrez, F Wandosell, ...
Scientific Reports 12 (1), 10092, 2022
442022
Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons
MHR Ludtmann, C Arber, F Bartolome, M de Vicente, E Preza, E Carro, ...
Journal of Biological Chemistry 292 (21), 8907-8917, 2017
422017
Recapitulation of pathological TDP-43 features in immortalized lymphocytes from sporadic ALS patients
D Posa, L Martínez-González, F Bartolomé, S Nagaraj, G Porras, ...
Molecular neurobiology 56, 2424-2432, 2019
362019
Altered cell cycle‐related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer’s disease [amyloid precursor protein/presenilin 1 (PS1)]
N Esteras, F Bartolomé, C Alquézar, D Antequera, U Munoz, E Carro, ...
European Journal of Neuroscience 36 (5), 2609-2618, 2012
342012
Obesity and neuroinflammatory phenotype in mice lacking endothelial megalin
F Bartolome, D Antequera, E Tavares, C Pascual, R Maldonado, ...
Journal of Neuroinflammation 14, 1-10, 2017
332017
From kinase inhibitors to multitarget ligands as powerful drug leads for Alzheimer's disease using protein‐templated synthesis
V Nozal, A García‐Rubia, EP Cuevas, C Pérez, C Tosat‐Bitrián, ...
Angewandte Chemie 133 (35), 19493-19503, 2021
302021
Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c. 709-1G> A PGRN mutation associated with FTLD-TDP dementia
C Alquezar, N Esteras, F Bartolomé, JJ Merino, A Alzualde, AL de Munain, ...
Neurobiology of aging 33 (2), 429. e7-429. e20, 2012
272012
The system can't perform the operation now. Try again later.
Articles 1–20